{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:54:01Z","timestamp":1783338841619,"version":"3.54.6"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/sap.0b013e31821bd4bc","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T07:48:02Z","timestamp":1306914482000},"page":"17-24","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of Prophylactic Anticoagulation, Deep Venous Thrombosis, and Heparin-Induced Thrombocytopenia in 21 Burn Centers in Germany, Austria, and Switzerland"],"prefix":"10.1097","volume":"67","author":[{"given":"Marc N.","family":"Busche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Knobloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Oliver","family":"Rennekampff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJM197607292950501","article-title":"Heparin-induced immune thrombocytopenia.","volume":"295","author":"Babcock","year":"1976","journal-title":"N Engl J Med"},{"key":"R2-7-20210202","first-page":"409","article-title":"Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.","volume":"136","author":"Rhodes","year":"1973","journal-title":"Surg Gynecol Obstet"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia.","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.athoracsur.2006.09.040","article-title":"Prevalence of heparin\/platelet factor 4 antibodies before and after cardiac surgery.","volume":"83","author":"Everett","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ahj.2007.03.013","article-title":"Beyond the platelet count: heparin antibodies as independent risk predictors.","volume":"153","author":"Stribling","year":"2007","journal-title":"Am Heart J"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2002-07-2201","article-title":"The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.","volume":"101","author":"Girolami","year":"2003","journal-title":"Blood"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2141.2005.05381.x","article-title":"Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.","volume":"128","author":"Pouplard","year":"2005","journal-title":"Br J Haematol"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BCR.0b013E31802C8929","article-title":"Arterial and venous complications of heparin-induced thrombocytopenia in burn patients.","volume":"28","author":"Scott","year":"2007","journal-title":"J Burn Care Res"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/BCR.0b013e3181ac05bf","article-title":"Heparin-induced thrombocytopenia in a nonthrombocytopenic patient with toxic epidermal necrolysis causing fatal outcome: is HIT still a HIT?","volume":"30","author":"Busche","year":"2009","journal-title":"J Burn Care Res"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/0003-4819-99-5-637","article-title":"Heparin-associated thrombosis without thrombocytopenia.","volume":"99","author":"Phelan","year":"1983","journal-title":"Ann Intern Med"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(94)91797-3","article-title":"Heparin-associated thrombosis despite normal platelet counts.","volume":"344","author":"Hach-Wunderle","year":"1994","journal-title":"Lancet"},{"key":"R15-7-20210202","first-page":"11","article-title":"Heparin as a cause of thrombus progression.","volume":"155","author":"Klement","year":"1996","journal-title":"Eur J Pediatr"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia.","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1997.d01-2056.x","article-title":"Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases.","volume":"96","author":"Kappers-Klunne","year":"1997","journal-title":"Br J Haematol"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2005-05-1824","article-title":"Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia.","volume":"106","author":"Greinacher","year":"2005","journal-title":"Blood"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP conference on antithrombotic and thrombolytic therapy.","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0305-4179(97)00031-4","article-title":"Blood platelets in severely injured burned patients.","volume":"23","author":"Takashima","year":"1997","journal-title":"Burns"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.burns.2009.04.014","article-title":"Factors affecting survival in adult patients with massive burns.","volume":"36","author":"Wang","year":"2010","journal-title":"Burns"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1365-2141.2001.02869.x","article-title":"Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia.","volume":"113","author":"Lindhoff-Last","year":"2001","journal-title":"Br J Haematol"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R","article-title":"Characterization of the humoral immune response in heparin-induced thrombocytopenia.","volume":"54","author":"Suh","year":"1997","journal-title":"Am J Hematol"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2004.01039.x","article-title":"Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.","volume":"2","author":"Zwicker","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia.","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1H569","article-title":"Argatroban anticoagulation in critically ill patients.","volume":"41","author":"Beiderlinden","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1592\/phco.2005.25.12.1736","article-title":"Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.","volume":"25","author":"Kiser","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jtcvs.2007.01.008","article-title":"Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.","volume":"133","author":"Koster","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2004-02-0621","article-title":"Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.","volume":"104","author":"Lubenow","year":"2004","journal-title":"Blood"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0030-1249617","article-title":"The current evidence-based guidelines regarding prophylaxis of venous thrombembolism and their relevance for plastic surgery [in German].","volume":"42","author":"Jokuszies","year":"2010","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/BCR.0b013e318204b2ff","article-title":"Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository.","volume":"32","author":"Pannucci","year":"2011","journal-title":"J Burn Care Res"},{"key":"R34-7-20210202","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"R35-7-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","article-title":"Enoxaparin and antifactor Xa levels in acute burn patients.","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"key":"R36-7-20210202","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1160\/TH08-08-0533","article-title":"Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies-distinguishing \u201csignal\u201d from \u201cnoise.\u201d","volume":"100","author":"Warkentin","year":"2008","journal-title":"Thromb Haemost"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0b013e31821bd4bc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:18:25Z","timestamp":1620973105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000637-201107000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e31821bd4bc","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}